e-learning
resources
Munich 2006
Wednesday 06.09.2006
Up to date management of bronchiectasis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung transplantation: the ideal treatment for diffuse disease?
P. Corris (Newcastle-Upon-Tyne, United Kingdom)
Source:
Annual Congress 2006 - Up to date management of bronchiectasis
Session:
Up to date management of bronchiectasis
Session type:
Symposium
Number:
4783
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Corris (Newcastle-Upon-Tyne, United Kingdom). Lung transplantation: the ideal treatment for diffuse disease?. Annual Congress 2006 - Up to date management of bronchiectasis
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
ERS clinical practice guidelines on bronchiectasis in children
Related content which might interest you:
Rapid decline in lung disease other than COPD: when should lung transplantation be considered?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007
Selection of emphysema patients for lung transplantation today
Source: Annual Congress 2004 - Lung transplantation: new insights in advanced lung disease and new drug developments - do they impact on selection criteria?
Year: 2004
Lung transplantation (LTx) for fibrotic diseases: a single centre experience
Source: Eur Respir J 2005; 26: Suppl. 49, 635s
Year: 2005
Paediatric lung transplantation
Source: Eur Respir J 2004; 24 : 839-845
Year: 2004
Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2018 – Rare lung diseases
Year: 2018
Paediatric lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=243
Year: 2003
Lung transplantation for diffuse bronchiectasis
Source: Annual Congress 2012 - Update on bronchiectasis
Year: 2012
The burden of sinus disease in CF candidates for lung transplantation
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016
Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Source: Eur Respir J 2012; 39: 1520-1533
Year: 2012
Panel discussion: COVID-19 and lung transplantation: how to handle?
Source: ERS webinar 2022
Access for REGISTERED non-members
Year: 2022
Idiopathic pulmonaryfibrosis: the native lung after single lung transplantation
Source: Eur Respir J 2003; 22: Suppl. 45, 328s
Year: 2003
Outcomes of lung transplantation for bronchiectasis
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012
Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Is lung transplantation still indicated?
Source: Annual Congress 2006 - Contemporary management of patients with end-stage emphysema
Year: 2006
Lung transplantation in silicosis, still rare
Source: Virtual Congress 2020 – Occupational lung diseases
Year: 2020
CF sinus disease after lung transplantation
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Current status of lung transplantation
Source: Eur Respir J 2003; 22: 57S-64S
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept